Results 81 to 90 of about 5,671 (220)
, 2021 Introduction: We aimed to study the effects of daily variation in solute intake on urine volume in patients with syndrome of inappropriate secretion of antidiuretic hormone secretion (SIADH), syndrome of nephrogenic antidiuresis (NSIAD), central diabetes
Decaux, Guy
core +1 more source
SIADH in Systemic JIA Resolving After Treatment With an IL-6 Inhibitor
, 2018 Interleukin-6 (IL-6) is implicated in the pathogenesis of both systemic juvenile idiopathic arthritis (SJIA) and syndrome of inappropriate secretion of antidiuretic hormone (SIADH), but the 2 have not been previously described as occurring together.
Shara R. Bialo +2 more
core +1 more source
Acute symptomatic hyponatremia in setting of SIADH as an isolated presentation of COVID-19
, 2020 The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is one of the most common causes of hyponatremia in hospitalized patients. Wide spectrum of etiologies associated with hyponatremia pose significant challenges in detecting and ...
Sundus Sardar (14571097) +5 more
core +1 more source
Pitfalls in SIADH-diagnosed hyponatraemia: Report of two cases
, 2018 In the majority of hospitalised patients with hyponatraemia, syndrome of inappropriate antidiuretic hormone secretion (SIADH) is the primary cause. Before considering SIADH, adrenal, thyroid and pituitary insufficiency should be ruled out.
Buikema, J W +3 more
core
, 1998 We report two cases with complex partial and secondarily generalized seizures, both on oxcarbazepine and vigabatrin, with additional lamotrigine in one case. Both died in a manner resembling SUDEP, i.e.
Børresen, Hans C. +2 more
core +1 more source
Long-term low-dose tolvaptan efficacy and safety in SIADH
, 2023 Purpose: Tolvaptan, a selective vasopressin V2-receptor antagonist, is approved for the treatment of SIADH-related hyponatremia, but its use is limited. The starting dose is usually 15 mg/day, but recent clinical experience suggests a lower starting dose
Irene Gagliardi +9 more
core +1 more source
, 2012 The syndrome of inappropriate ADH secretion (SIADH), also termed ''syndrome of inappropriate antidiuresis (SIAD)'', is an often unrecognized cause of hypotonic hyponatremia, arising from ectopic release of ADH in lung cancer or as a side effect of ...
Parenti, G +7 more
core
SIADH secondary to rhino‐orbito‐cerebral mucormycosis: A case report
Key Clinical Message Invasive fungal mucormycosis and its outcome as SIADH and orbital apex syndrome is uncommon. Mucormycosis in paranasal sinuses can even lead to intracranial invasion and its treatment with the use of amphotericin B can cure improve ...
Prahlad Gupta +5 more
core +1 more source
The Pan African Medical Journal, 2019 Le syndrome de sécrétion inappropriée de l'hormone antidiurétique (SIADH) représenterait environ 50% de tous les cas diagnostiqués d'hyponatrémie. Seule une faible proportion de SIADH serait d'origine médicamenteuse. Nous rapportons le cas d'une patiente
Assia Fadili +4 more
doaj +1 more source
SIADH et traitement par vaptans
, 2012 The vaptans are non-peptide arginine-vasopressin-receptor antagonists, that are orally and intravenously active. A few vaptans have undergone sufficient clinical development to be on the market.
Decaux, Guy
core +1 more source